Literature DB >> 22652091

The burden of atrial fibrillation on the hospital sector in Canada.

Daria J O'Reilly1, Robert B Hopkins, Jeff S Healey, Paul Dorian, Luc Sauriol, Jean-Eric Tarride, Natasha Burke, Ronald A Goeree.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a common disease that frequently requires acute hospital care; however, the cost of hospital care in Canada has not been reported. The purpose of this study was to estimate the cost of AF related to hospital-based care in Canada.
METHODS: Analyses were conducted with 2 national administrative databases for the fiscal year 2007-2008. Databases included information for hospital admissions, day operations, and ambulatory care. Records with a most responsible diagnosis of AF, atrial flutter, or a diagnosis related to AF with a concomitant comorbidity of AF were included. Hospital costs were estimated, in 2010 Canadian dollars, by applying an average cost per weighted case to the resource intensity weight for each admission or visit and then adding the separate billable fee for admissions, surgical procedures, and interventions.
RESULTS: In 2007-2008, the number of acute care admissions with AF as the most responsible diagnosis was 22,823, same-day surgical procedures was 5707, and emergency department visits was 58,066. The hospital costs attributable to AF were $815 million in 2010 Canadian dollars: $710 million for hospitalizations; $32 million for same-day surgical procedures; and $73 million for emergency department visits. Most of the acute care costs were for hospitalizations when AF was listed as a comorbidity ($558 million, or 69%).
CONCLUSION: AF results in a substantial cost burden to the acute care hospital sector. Current hospital costs in AF patients are driven by the consequences of AF, while the costs for specific treatments for AF are relatively low.
Copyright © 2013 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22652091     DOI: 10.1016/j.cjca.2012.03.023

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  10 in total

1.  Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation.

Authors:  Ambili Menon; Liang Hong; Eleonora Savio-Galimberti; Arvind Sridhar; Seock-Won Youn; Meihong Zhang; Kaylen Kor; Marcia Blair; Sabina Kupershmidt; Dawood Darbar
Journal:  J Mol Cell Cardiol       Date:  2019-05-08       Impact factor: 5.000

2.  The Current and Future Hospitalization Cost Burden of Syncope in Canada.

Authors:  Dat T Tran; Robert S Sheldon; Padma Kaul; Roopinder K Sandhu
Journal:  CJC Open       Date:  2020-03-04

3.  Factors Associated With Patient Engagement in Shared Decision-Making for Stroke Prevention Among Older Adults with Atrial Fibrillation.

Authors:  Jordy Mehawej; Jane Saczynski; Hawa O Abu; Marc Gagnier; Benita A Bamgbade; Darleen Lessard; Katherine Trymbulak; Connor Saleeba; Catarina I Kiefe; Robert J Goldberg; David D McManus
Journal:  Can Geriatr J       Date:  2021-09-01

4.  Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis.

Authors:  Yan Xu; Anne M Holbrook; Christopher S Simpson; Dar Dowlatshahi; Ana P Johnson
Journal:  CMAJ Open       Date:  2013-10-16

5.  Identifying predictors of cumulative healthcare costs in incident atrial fibrillation: a population-based study.

Authors:  Maria C Bennell; Feng Qiu; Andrew Micieli; Dennis T Ko; Paul Dorian; Clare L Atzema; Sheldon M Singh; Harindra C Wijeysundera
Journal:  J Am Heart Assoc       Date:  2015-04-23       Impact factor: 5.501

6.  Comparison of health-related quality of life in patients with atrial fibrillation treated with catheter ablation or antiarrhythmic drug therapy: a systematic review and meta-analysis protocol.

Authors:  Katherine S Allan; Shaunattonie Henry; Theresa Aves; Laura Banfield; J Charles Victor; Paul Dorian; Jeff S Healey; Jason Andrade; Sandra Carroll; Michael McGillion
Journal:  BMJ Open       Date:  2017-08-21       Impact factor: 2.692

7.  Measuring the effect of nurse practitioner (NP)-led care on health-related quality of life in adult patients with atrial fibrillation: study protocol for a randomized controlled trial.

Authors:  Marcie J Smigorowsky; Colleen M Norris; Micheal Sean McMurtry; Ross T Tsuyuki
Journal:  Trials       Date:  2017-08-03       Impact factor: 2.279

8.  Canada-wide mixed methods analysis evaluating the reasons for inappropriate emergency department presentation in patients with a history of atrial fibrillation: the multicentre AF-ED trial.

Authors:  Kathryn Lauren Hong; Corinne Babiolakis; Brigita Zile; Milena Bullen; Sohaib Haseeb; Frank Halperin; Corinne M Hohl; Kirk Magee; Roopinder K Sandhu; Simon Yu Tian; Ashley Kennedy; Trudie Lobban; Zana Mariano; Paul Dorian; Paul Angaran; Marilyn Evans; Peter Leong-Sit; Benedict M Glover
Journal:  BMJ Open       Date:  2020-04-16       Impact factor: 2.692

9.  Geographic and temporal variation in the treatment and outcomes of atrial fibrillation: a population-based analysis of national quality indicators.

Authors:  Derek S Chew; Flora Au; Yuan Xu; Braden J Manns; Marcello Tonelli; Stephen B Wilton; Brenda Hemmelgarn; Shiying Kong; Derek V Exner; Amity E Quinn
Journal:  CMAJ Open       Date:  2022-08-02

10.  An Update on the Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation and Atrial Flutter.

Authors:  Roopinder K Sandhu; Stephen B Wilton; Jennifer Cruz; Clare L Aztema; Kendra MacFarlane; Robert McKelvie; Laurie Lambert; Kathy Rush; Rodney Zimmerman; Garth Oakes; Mark Deyell; D George Wyse; Jafna L Cox; Allan Skanes
Journal:  CJC Open       Date:  2019-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.